Canakdo, a global healthcare company leveraging healthcare services using privacy-safe technology that brings together patients and healthcare professionals.
Do not miss our Poster presentation at
#DGHO 2021 Congress,
On AI-based Smartphone APP for QTc diagnostics using a single-lead ECG for oncological routine.
Our Project Manager Lena is the presenter of the poster.
#event#AI#oncology#PosterPresentation#dgho
Upcoming Event - Poster Presentation At #DGHO 2021 On AI-based Smartphone APP for QTc diagnostics using a single-lead ECG for oncological routine
by our Project Manager Lena-Sophie Fink
#event#posterpresentation#oncology#ai#CANKADO
Launching today-‘Colloquium Senologie 2021/2022’, a book series on practice-changing developments in #breastcancer therapy.#CANKADO is proud to have contributed to the Chapter,‘Digital Health Applications’, in the upcoming edition of Colloquium Senologie.
https://t.co/V0GiKtMjct
CANKADO co-authors in ‘Colloquium Senologie 2021/2022’. This is a book series aimed at all doctors who are dedicated to the care of breast cancer patients.
When: 01 July 2021 between 17:00hr-19:00hr
Where: Online event program, colloquium Senologie2021-22(https://t.co/WPsCiHrsfS)
CANKADO co-authors in ‘Colloquium Senologie 2021/2022���. This is a book series aimed at all doctors who are dedicated to the care of breast cancer patients.
When: 01 July 2021 between 17:00hr-19:00hr
Where: Online event program, colloquium Senologie2021-22(https://t.co/WPsCiHrsfS)
Know more on PRO-React Onco, First ‘App on Prescription’ for Breast Cancer Treatment Support.
PRO-React Onco can now be prescribed as DiGA in Germany to accompany the treatment of breast cancer patients.
#diga#breastcancer#ehealth#DiGA#oncology
https://t.co/E2bzOjfLId
CANKADO PRO-React Onco developed by CANKADO Service GmbH is approved as a #DiGA(Digital Health Application) by Federal Institute for Drugs and Medical Devices ( BfArM ) and has been added to the DiGA directory.
https://t.co/OFp9mVYl9n
#digitalhealth#breastcancer#CANKADO
CANKADO's #telecardiology application, QTc Tracker's striking results and the substantial workflow presented in the digital poster at Quality of #Cancercare (QoCC) 2021 won one of the three poster prizes of the congress QoCC 2021
https://t.co/F3Fm39HJEo
CANKADO together with Ludwig Maximilian University of Munich, West German Study Group and Kliniken Essen-Mitte GmbH is to present a digital poster at the virtual congress, ‘Quality of Cancer Care’ (QoCC) 2021.
#qocc2021#cancercare#telecardiology
https://t.co/dwOcTPRNT6
The new clinical trial, ADAPTlate conducted by West German Study Group enrolled its first patients who are using the CANKADO #ehealth system as part of the study to monitor their Quality of Life (QoL).
#clinicaltrials#cancercare#digitalhealth
https://t.co/SZpqZLCSOm
Together with WSG (West German Study Group), #CANKADO has developed the EnRep tool to predict the probability of response to #endocrinetherapy in early-stage #breastcancer patients. EnReP has been introduced today at the #SABCS20@SABCSSanAntonio#bcsm
https://t.co/eKXcSnThog